View Author
cancer breast brca 1 mutation carrier study university breast cancer risk genetic research department genetics service centre center breast cancer hospital rhamm analysis institute association service aurka figure depletion polarization expression foundation cancer risk netherland oncology genet grant centrosome modifier mutation carriers table acini allele brca 1 depletion health result microtubule epithelial medicine brca 2 mcf 10a cells brca 2 carriers variant tpx 2 family differentiation subject variation ratio sample 703-rhamm estimate cancer research consortium control tumor brca 2 mutations carcinogenesi activity protein genotype article factor brca 1 function epithelial apicobasal polarization image culture 557ser evidence function per-allele experiment hazard women breast cancer res
4 Most Recent Publications
|
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
(Article)
Maxwell, C.A. Benitez, J. Mohan, P. Buys, S.S. John, E.M. Miron, A. Southey, M.C. Daly, M. Schmutzler, R.K. Wappenschmidt, B. Meindl, A. Arnold, N. Deissler, H. Català, I. Varon-Mateeva, R. Sutter, C. Niederacher, D. Imyamitov, E. Sinilnikova, O. Stoppa-Lyonne, D. Mazoyer, S. Verny-Pierre, C. Castera, L. Pauw, A. de Petit, A. Bignon, Y.-J. Uhrhammer, N. Peyrat, J.-P. Vennin, P. Ferrer, S.F. Collonge-Rame, M.-A. Mortemousque, I. Spurdle, A.B. Beesley, J. Healey, S. Aguilar, H. Barcellos-Hoff, M.H. Vidal, M. Gruber, S.B. Lazaro, C. Capellá, G. McGuffog, L. Nathanson, K.L. Antoniou, A.C. Chenevix-Trench, G. Fleisch, M.C. Villanueva, A. Moreno, V. Pujana, M.A. Aytes, A. Serra-Musach, J. Rennert, G. Lejbkowicz, F. Peterlongo, P. Gómez-Baldó, L. Manoukian, S. Peissel, B. Ripamonti, C.B. Bonanni, B. Viel, A. Allavena, A. Bernard, L. Radice, P. Friedman, E. Kaufman, B. Osorio, A. Laitman, Y. Dubrovsky, M. Milgrom, R. Jakubowska, A. Cybulski, C. Górski, B. Jaworska, K. Durda, K. Sukiennicki, G. Lubinski, J. Bonifaci, N. Shugart, Y.Y. Domchek, S.M. Letrero, R. Weber, B.L. Hogervorst, F.B.L. Rookus, M.A. Collée, J.M. Devilee, P. Ligtenberg, M. Luijt, R.B. van der Fernández-Ramires, R. Aalfs, C. Waisfisz, Q. Wijnen, J.T. Roozendaal, C.E.P. van Easton, D.F. Peock, S. Cook, J. Oliver, C. Frost, D. Harrington, P. Costes, S.V. Lalloo, F. Eeles, R. Izatt, L. Chu, C. Eccles, D. Douglas, F. Brewer, C. Nevanlinna, H. Heikinen, T. Couch, F.J. Guinó, E. Lindor, N.M. Wang, X. Godwin, A.K. Caligo, M.A. Lombardi, G. Loman, N. Karlsson, P. Ehrencrona, H. Wachenfeldt, A. von Barkardottir, R.B. Chen, H. Hamann, U. Rashid, M.U. Lasa, A. Caldes, T. Andres, R. Schmitt, M. Assmann, V. Stevens, K. Offit, K. Curado, J. Evans, G.J.R. Tilgner, H. Guigó, R. Aiza, G. Brunet, J. Castellsagué, J. Martrat, G. Urruticoechea, A. Blanco, I. Tihomirova, L. Goldgar, D. |
2011-11-01
|
|
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers
(Article)
Spurdle, A.B. Marquart, L. Gschwantler-Kaulich, D. Blum, J.L. Tung, N. Weitzel, J.N. Lynch, H. Garber, J. Easton, D.F. Peock, S. Cook, J. Oliver, C. McGuffog, L. Frost, D. Conroy, D. Evans, D.G. Lalloo, F. Eeles, R. Izatt, L. Davidson, R. Chu, C. Eccles, D. Selkirk, C.G. Healey, S. Daly, M. Isaacs, C. Stoppa-Lyonnet, D. Buecher, B. Belotti, M. Mazoyer, S. Barjhoux, L. Verny-Pierre, C. Lassett, C. Dreyfus, H. Sinilnikova, O. Pujol, P. Collonge-Rame, M.-A. Rookus, M.A. Verhoef, S. Kriege, M. Hoogerbrugge, N. Ausems, M.G.E.M. Os, T.A.M. van Wijnen, J.T. Devilee, P. Wan, F. Meijers-Heijboer, H. Blok, M.J. Heikinen, T. Nevanlinna, H. Jakubowska, A. Lubinski, J. Huzarski, T. Byrski, T. Durocher, F. Couch, F.J. Chenevix-Trench, G. Lindor, N.M. Wang, X. Thomassen, M. Domchek, S.M. Nathanson, K.L. Caligo, M.A. Jernström, H. Liljegren, A. Ehrencrona, H. Karlsson, P. Beesley, J. Ganz, P.A. Olopade, O.I. Tomlinson, G. Neuhausen, S.L. Antoniou, A.C. Chenevix-Trench, G. Rebbeck, T.R. Singer, C.F. Dressler, A.-C. |
2011-05-01
|
|
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
(Article)
Ramus, S.J. kartsonaki, C. Wang, X. Collonge-Rame, M.-A. Vénat-Bouvet, L. Fert-Ferrer, S. Miron, A. Buys, S.S. Hopper, J. Daly, M. John, E.M. Terry, M-B. Goldgar, D. Fredericksen, Z. Hansen, T.V.O. Jønson, L. Ejlertsen, B. Agnarsson, B.A. Offit, K. Kirchhoff, T. Vijai, J. Dutra-Clarke, A. Przybylo, J.A. Montagna, M. Peterlongo, P. Casella, C. Imyanitov, E.N. Janavicius, R. Blanco, I. Lazaro, C. Moysich, K.B. Karlan, B.Y. Gross, J. Beattie, M.S. Schmutzler, R.K. Manoukian, S. Wappenschmidt, B. Meindl, A. Ruehl, I. Fiebig, B. Sutter, C. Arnold, N. Deissler, H. Varon-Mateeva, R. Kast, K. Niederacher, D. Peissel, B. Gadzicki, D. Caldes, T. Hoya, M. de La Nevanlinna, H. Aittomäki, K. Simard, J. Soucy, P. Spurdle, A.B. Holland, H. Easton, D.F. Zaffaroni, D. Antoniou, A.C. Asperen, C.J. van Roversi, G. Barile, M. Viel, A. Allavena, A. Gayther, S.A. Ottini, L. Papi, L. Gismondi, V. Capra, F. Radice, P. Greene, M.H. Mai, P.L. Andrulis, I.L. Glendon, G. Ozcelik, H. Pharoah, P.D.P. Thomassen, M. Gerdes, A-M. Kruse, T.A. Cruger, D. Jensen, U.B. Caligo, M.A. Olsson, H. Kristoffersson, U. Lindblom, A. Arver, B. Sinilnikova, O. Karlsson, P. Stenmark-Askmalm, M. Borg, A. Neuhausen, S.L. Ding, Y.C. Nathanson, K.L. Domchek, S.M. Jakubowska, A. Lubinski, J. Huzarski, T. Beesley, J. Byrski, T. Gronwald, J. Górski, B. Cybulski, C. Dbniak, T. Osorio, A. Durán, M. Tejada, M.-I. Benitez, J. Hamann, U. Chenevix-Trench, G. Rookus, M.A. Verhoef, S. Tilanus-Linthorst, M.A. Vreeswijk, M.P. Bodmer, D. Ausems, M.G.E.M. Os, T.A.M. van Blok, M.J. Meijers-Heijboer, H. Peock, S. McGuffog, L. Cook, J. Oliver, C. Frost, D. Dunning, A.M. Evans, D.G. Eeles, R. Pichert, G. Cole, T.J. Hodgson, S.V. Brewer, C. Healey, S. Morrison, P.J. Porteous, M.E. Kennedy, M.J. Rogers, M.T. Side, L. Donaldson, A. Gregory, H. Godwin, A.K. Stoppa-Lyonnet, D. Moncoutier, V. Couch, F.J. Castera, L. Mazoyer, S. Barjhoux, L. Bonadona, V. Leroux, D. Faivre, L. Lidereau, R. Nogues, C. Bignon, Y.-J. Prieur, F. |
2011-01-19
|
|
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers
(Article)
Walker, L. Fredericksen, Z. Tirapo, C. Giraud, S. Mazoyer, S. Muller, D.W. Fricker, J.P. Delnatte, C.D. Schmutzler, R.K. Wappenschmidt, B. Engel, C. Schönbuchner, I. Wang, X. Deissler, H. Meindl, A. Hogervorst, F.B.L. Verheus, M. Hooning, M. Ouweland, A.M.W. van den Nelen, M.R. Ausems, M.G.E.M. Aalfs, C. Asperen, C.J. van Tarrell, R. Devilee, P. Gerrits, M.M. Waisfisz, Q. Szabo, C. Easton, D.F. Peock, S. Cook, M. Oliver, C. Frost, D. Harrington, P. Pankratz, V.S. Evans, D.G. Lalloo, F. Eeles, R. Izatt, L. Chu, C. Davidson, R. Eccles, D. Ong, K.R. Cook, J. Rebbeck, T.R. Lindor, N.M. Nathanson, K.L. Domchek, S.M. Singer, C.F. Gschwantler-Kaulich, D. Dressler, C. Pfeiler, G. Godwin, A.K. Heikinen, T. Nevanlinna, H. Agnarsson, B.A. Beesley, J. Caligo, M.A. Olsson, H. Kristoffersson, U. Liljegren, A. Arver, B. Karlsson, P. Melin, B. Sinilnikova, O. McGuffog, L. Antoniou, A.C. Healey, S. Chenevix-Trench, G. Spurdle, A.B. Couch, F.J. Chen, X. Stoppa-Lyonnet, D. |
2010-11-29
|
